Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALLPhi)

This study has been terminated.
(The study was terminated due to excessive toxicity of the chemotherapy and low compliance to the protocol scheme.)
Sponsor:
Information provided by (Responsible Party):
Rony Schaffel, Universidade Federal do Rio de Janeiro
ClinicalTrials.gov Identifier:
NCT00905398
First received: May 15, 2009
Last updated: January 2, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2013
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)